IRIS
PISANI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.573
EU - Europa 2.161
AS - Asia 1.799
AF - Africa 66
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 7.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.499
IT - Italia 1.139
SG - Singapore 706
CN - Cina 494
HK - Hong Kong 388
FI - Finlandia 172
VN - Vietnam 142
IE - Irlanda 130
DE - Germania 129
UA - Ucraina 121
RU - Federazione Russa 102
NL - Olanda 86
CA - Canada 68
CI - Costa d'Avorio 60
FR - Francia 49
GB - Regno Unito 47
SE - Svezia 46
RO - Romania 45
IN - India 31
MK - Macedonia 22
BE - Belgio 12
IR - Iran 12
TR - Turchia 11
BR - Brasile 10
RS - Serbia 10
BG - Bulgaria 9
PL - Polonia 9
AT - Austria 8
CH - Svizzera 6
MX - Messico 6
EG - Egitto 4
EU - Europa 4
GR - Grecia 4
JP - Giappone 4
SI - Slovenia 4
IL - Israele 3
PE - Perù 3
VE - Venezuela 3
AU - Australia 2
ES - Italia 2
IM - Isola di Man 2
IQ - Iraq 2
LV - Lettonia 2
MY - Malesia 2
BD - Bangladesh 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HR - Croazia 1
ID - Indonesia 1
MA - Marocco 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7.622
Salva come PNG Salva come JPEG
Città #
Singapore 566
Chandler 553
Hong Kong 387
Santa Clara 283
Napoli 241
Millbury 219
Ashburn 166
Princeton 158
Nanjing 145
Dong Ket 142
Beijing 121
Jacksonville 119
Boston 113
Naples 108
Des Moines 98
Wilmington 95
Amsterdam 74
Rome 60
Ottawa 57
Lawrence 56
Dublin 53
Milan 49
Bucharest 45
Nanchang 39
Seattle 38
Caserta 35
Shenyang 29
Hebei 28
Helsinki 22
Boardman 21
Redwood City 20
Woodbridge 20
Norwalk 18
Washington 18
Jiaxing 17
Augusta 15
Tianjin 15
Houston 14
Nuremberg 14
Turin 13
Frankfurt am Main 12
Los Angeles 12
Ann Arbor 11
Courcelles 11
Kunming 11
Moscow 10
Sciacca 10
Duncan 9
Skopje 9
Sofia 9
Changsha 8
Fairfield 8
Falkenstein 8
Falls Church 8
San Mateo 8
Toronto 8
Majdanpek 7
Mugnano di Napoli 7
New York 7
Salerno 7
Dallas 6
Kronberg 6
London 6
Pune 6
San Giorgio Del Sannio 6
Afragola 5
Baar 5
Bari 5
Casoria 5
Council Bluffs 5
Guangzhou 5
Leawood 5
Munich 5
Orange 5
Riccione 5
Saponara 5
Sesto San Giovanni 5
Vienna 5
Antalya 4
Frattamaggiore 4
Genoa 4
Hangzhou 4
Jinan 4
Lowicz 4
Marano Di Napoli 4
Mexico City 4
Mountain View 4
Ningbo 4
Redmond 4
San Francisco 4
San Giorgio La Molara 4
Shanghai 4
Torino 4
Abano Terme 3
Altamura 3
Bergamo 3
Bologna 3
Brescia 3
Formia 3
Genova 3
Totale 4.640
Salva come PNG Salva come JPEG
Nome #
Polimirfismo del gene dell'ACE ed eritrocitosi nel trapianto di rene 339
Il nefrologo nel trattamento dell’iperammoniemia da disordini del ciclo dell’urea 128
Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease 116
Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review 91
Parapelvic cysts, a distinguishing feature of renal Fabry Disease. 81
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer 80
Effect of a Short-Course Treatment with Synbiotics on Plasma p-Cresol Concentration in Kidney Transplant Recipients. 75
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 67
Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study. 66
A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency 66
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 66
Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study 66
Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease 66
Immunosuppression and multiple primary malignancies in kidney transplanted patients. A single-institute study 64
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial 62
Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter? 61
Endocrine dysfunction in patients with Fabry disease 61
6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial 61
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group 60
Current tissue molecular markers in colorectal cancer: A literature review 60
Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease 59
Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations 56
Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media 55
EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects. 54
Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis 54
Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study 53
A strange epigastric pain. 52
Cardiac performance during exercise in patients with Fabry's disease 52
Pituitary function and morphology in Fabry disease. 52
Effects of atorvastatin on renal function in patients with chronic renal failure. PMID: 51
Atorvastatin improves the course of ischemic acute renal failure in aging rats 51
Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial 50
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial 50
Inibizione del'angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 49
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography 49
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. 48
ACE-Inhibitor (ACE-i) and Eryhrocytosis in Renal Transplantation 48
Cerebrovascular and Brain Abnormalities In Autosomal-Dominant Polycystic Kidney Disease: Role Of 3d Time-of-Flight Magnetic Resonance Angiography 48
Arginase inhibition slows the progression of renal failure in rats with renal ablation 47
Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. Am J Kidney Dis. 2005 Jul;46(1):120-7. 46
Thyroid function in Fabry disease before and after enzyme replacement therapy. 46
ADPKD and metformin: from bench to bedside 46
Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and agalsidase alpha in cultured fibroblasts from patients with Fabry disease 45
A clinical case of a giant lymphocele (LC) in a patient with a recent renal transplant is described 45
The Choice of the Iodinated Radiographic Contrast Media to Prevent Contrast-Induced Nephropathy 45
Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors 45
Terapia enzimatica sostitutiva nella malattia di Fabry: cosa abbiamo imparato dallo switch? 45
Redefining the Pulvinar Sign in Fabry Disease 45
Inibizione del'angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale. 44
Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry disease. 44
Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995–2019 44
Ketogenic diet in ADPKD patient 44
Progression of chronic renal failure in remnant rats: role of arginase inhibition 43
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 43
Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival 43
Optical Coherence Tomography Angiography Findings in Fabry Disease 43
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 42
Antiproteinuric effect of angiotensin II blockade in patients with IgA nephropathy. 41
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease. 41
Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease 41
Treatment with Agalsidase Alfa during Pregnancy in a Heterozygous Female with Fabry Disease 41
What indication, morbidity and mortality for central pancreatectomy in oncological surgery? A systematic review. 41
Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients 41
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: A randomized trial 40
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group 40
Motor involvement in Fabry disease 40
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 40
Effects of Ha-Ras inhibition on ischemic acute renal failure in the rat 39
Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. 39
Reversal of radiocontrast medium toxicity in human renal proximal tubular cells by white grape juice extract 39
Early Biomarkers of Fabry Nephropathy: A Review of the Literature. 39
Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients] 38
Effects of atorvastatin on renal function in patients with chronic renal failure. 38
Endothelial-mediated coronary flow reserve in patients with Anderson-Fabry disease 38
Differential activation of signaling pathways by low-osmolar and Iso-osmolar radiocontrast agents in human renal tubular cells 38
Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease 38
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 38
Cisti epatica gigante in una paziente affetta da malattia policistica autosomica dominante 37
Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. 37
La nefrotossicità dei farmaci immunosoppressori.Dalla ricerca alla clinica 37
Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease 37
Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. 36
A clinical case of a giant lymphocele (LC) in a patient with a recent renal transplant is described] G Ital Nefrol 36
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. 36
The role of immunosuppressive therapy in aneurysmal degeneration of hemodialysis fistulas in renal transplant patients: Aneurysmatic arteriovenous fistula in transplant patients 36
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant 35
Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature 35
Fabry's disease: a comparison of the effectiveness of two different enzyme replacement therapies 35
New insights for early assessment of cardiac involvement in Anderson-Fabry disease 35
An unusual case of tuberous sclerosis incidentally discovered in adulthood: case report and review of the literature 35
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis. 35
Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art 34
Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients 34
First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease 34
Atrial septum aneurysm: an unusual manifestation in ADPKD? 34
Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease 34
Renal denervation in ADPKD: an exceptional case 34
Switch to agalsidase alfa after shortage of agalsidase beta in Fabry disease: a systematic review and meta-analysis of the literature. 34
Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease 34
Reduced intracranial volume in Fabry Disease: Evidence of abnormal neurodevelopment? 34
Totale 5.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020364 0 0 0 0 0 0 6 24 65 68 100 101
2020/2021672 15 23 46 27 64 73 33 32 80 28 85 166
2021/20221.185 20 4 11 13 15 37 37 52 113 109 261 513
2022/20231.352 224 125 50 119 144 147 19 126 221 81 74 22
2023/20241.193 56 277 108 62 69 112 24 103 27 25 247 83
2024/20251.882 342 320 38 110 126 370 576 0 0 0 0 0
Totale 8.050